Everything you care about in one place
Follow feeds: blogs, news, RSS and more. An effortless way to read and digest content of your choice.
Get Feederfiercebiotech.com
FierceBiotech
Get the latest updates from FierceBiotech directly as they happen.
Follow now 337 followers
Latest posts
Last updated about 3 hours ago
New Hepta blood test could predict GLP-1 response
about 3 hours ago
While GLP-1s like Ozempic and Wegovy are being widely prescribed for weight...
Setting a new standard in prefillable syringe systems
about 13 hours ago
How a fully integrated syringe system helps pharma teams cut risk, time...
Trump plans to fire FDA chief Marty Makary: report
about 13 hours ago
President Donald Trump has approved a plan to fire FDA Commissioner Marty...
A protective gene sent to the liver cleared amyloid from mouse brains, sparking hope for an Alzheimer’s gene therapy
about 17 hours ago
The calling card of Alzheimer’s disease is a buildup of misfolded amyloid...
Analysts cut enGene cancer sales forecast after updated data widen gap to J&J
about 20 hours ago
Leerink Partners analysts slashed their sales forecast for enGene Therapeutics’ bladder cancer...
Odyssey voyages to Nasdaq with $304M IPO to fund autoimmune, inflammatory pipeline
about 22 hours ago
Odyssey Therapeutics has become the latest biotech to voyage to the public...
Chutes & Ladders—Biopharma veteran takes her CEO Cue
1 day ago
Not long after the departure of former CEO Usman Azam, a new...
MRD as a Decision Engine: Rethinking Oncology Trial Design from Early Phase to Registration
1 day ago
As MRD shifts from prognostic marker to intervention trigger, sponsors must rethink...
Banyan BioInnovations puts down roots with $100M, Icon partnership
1 day ago
Banyan BioInnovations is debuting with more than $100 million aimed at developing...
BeOne shelves 5 cancer programs, halts phase 2 rheumatoid arthritis trial
2 days ago
BeOne Medicines has shaken up its early pipeline, dropping five phase 1...
Antibodies that stop measles from stabbing cells could become new treatments for the surging virus, study suggests
2 days ago
Though a measles vaccine has existed for more than 60 years, much...
FDA to reconsider shock rejection of cell therapy Ebvallo. Could uniQure be next?
2 days ago
After a surprise rejection in January, the FDA has agreed to reconsider...